Reviews of Medications for Autistic People

This page provides a select list of scientific reviews of interventions, treatments and therapies for autistic people which use medications.

If you know of any other publications we should list on this page please email info@informationautism.org

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.

Related Publications

• Accordino R. E. et al. (2016) Psychopharmacological interventions in autism spectrum disorder. Expert Opinion on Pharmacotherapy. 17(7), Read Abstract (New Window)
  
  
• Agency for Healthcare Research and Quality (2017) Medical therapies for children with autism spectrum disorder: An update. Rockville, MD: Agency for Healthcare Research and Quality Read Abstract (New Window) Read Full (New Window)
  
  
• Anagnostou E., Hansen R. L. (2011) Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications. Current Opinions in Pediatrics. 23(6), Read Abstract (New Window)
  
  
• Bramble D. (2011) Psychopharmacology in children with intellectual disability. Advances in Psychiatric Treatment. 17 Read Abstract (New Window)
  
  
• Brkanac Z., Raskind W. H., King B. H. (2008) Pharmacology and genetics of autism: implications for diagnosis and treatment. Personalized Medicine. 5(6), Read Abstract (New Window) Read Full (New Window)
  
  
• Choueiri R. N., Zimmerman A. W. (2017) New assessments and treatments in ASD. Current Treatment Options in Neurology. 19(6), Read Abstract (New Window)
  
  
• Coury D. (2010) Medical treatment of autism spectrum disorders. Current Opinion in Neurology. 23(2), Read Abstract (New Window)
  
  
• Coury D. (2011) Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders. Evidence Based Mental Health. 127(5), Read Abstract (New Window) Read Full (New Window)
  
  
• Earle J. F. (2016) An introduction to the psychopharmacology of children and adolescents with autism spectrum disorder. Journal of Child and Adolescent Psychiatric Nursing. 29(2), Read Abstract (New Window)
  
  
• Eissa N. et al. Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder. Frontiers in Neuroscience. Read Full (New Window)
  
  
• Elvins R., Green J. (2010) Pharmacological management of core and comorbid symptoms in autism-spectrum disorder. Advances in Psychiatric Treatment. 16(5), Read Abstract (New Window)
  
  
• Floyd E. F., McIntosh D. E. (2009) Current practice in psychopharmacology for children and adolescents with autism spectrum disorders. Psychology in the Schools. 46(9), Read Abstract (New Window)
  
  
• Howes O. D. et al. Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. Journal of Psychopharmacology. Read Abstract (New Window)
  
  
• Jobski K. et al. (2016) Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review. Acta Psychiatrica Scandinavica. Read Abstract (New Window)
  
  
• Lee Y. J. et al. (2014) Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder. Clinical Psychopharmacology and Neuroscience. Read Abstract (New Window) Read Full (New Window)
  
  
• Leskovec T. J., Rowles B. M., Findling R. L. (2008) Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harvard Review of Psychiatry. 16(2), Read Abstract (New Window)
  
  
• Mandell D. S. et al. (2008) Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics. 121(3), Read Abstract (New Window) Read Full (New Window)
  
  
• Nazeer A. (2011) Psychopharmacology of autistic spectrum disorders in children and adolescents. Pediatric Clinics of North America. 58(1), Read Abstract (New Window)
  
  
• Parikh M., Kolevzon A., Hollander E. (2008) Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability Journal of Child and Adolescent Psychopharmacology. 18(2), Read Abstract (New Window)
  
  
• Peñagarikan O. (2014) New therapeutic options for autism spectrum disorder: Experimental evidences. Experimental Neurobiology. 24(4), Read Abstract (New Window) Read Full (New Window)
  
  
• Politte L. C., Henry C. A., McDougle C. J. (2014) Psychopharmacological interventions in autism spectrum disorder. Harvard Review of Psychiatry. 22(2), Read Abstract (New Window)
  
  
• Stigler K. A., McDougle C. J. (2008) Pharmacotherapy of irritability in pervasive developmental disorders. Child and Adolescent Psychiatric Clinics of North America. 17(4), Read Abstract (New Window)
  
  
• Sung M., Fung D. S. S., Ooi Y. P. (2010) Pharmacological management in children and adolescents with pervasive developmental disorder. Australian and New Zealand Journal of Psychiatry. 44(5), Read Abstract (New Window)
  
  
• Sung M. et al. (2014) What's in the pipeline? Drugs in development for autism spectrum disorder. Neuropsychiatric Disease and Treatment. (10), Read Abstract (New Window) Read Full (New Window)
  
  
• Taylor L. J. (2016) Psychopharmacologic intervention for adults with autism spectrum disorder: A systematic literature review. Research in Autism Spectrum Disorders. 25 Read Abstract (New Window)
  
  
• West L., Waldrop J., Brunssen S. (2009) Pharmacologic treatment for the core deficits and associated symptoms of autism in children. Journal of Pediatric Health Care. 23(2), Read Abstract (New Window)
  
  
• Wink L. K. et al. (2010) Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opinion on Emerging Drugs. 15(3), Read Abstract (New Window)
  
  

Quick link:

https://informationautism.org/medication-reviews

Updated

15 Jun 2022